A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis
Clinical trial NCT05692154 · COMPLETED
Trial details
- NCT number
- NCT05692154
- Sponsor
- Opella Healthcare Group SAS, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2023-03-14
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.